Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. ALKS

Market Cap: $7.71B

AP

Alkermes plc

ALKS
NASDAQUSD
Purchase ALKS
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin84.56%
EBITDA Margin13.07%
EBIT Margin9.38%
Pre-tax Margin5.84%
Net Profit Margin3.97%
Earnings Yield0.86%
Valuation Multiples
Price / Book4.23
Price / Sales4.62
Price / Earnings114.07
PEG-1.40
Forward PEG-0.47
EV / Sales5.26
EV / EBITDA40.24
EV / Operating Cash Flow34.93
EV / Free Cash Flow39.58
Price / Free Cash Flow34.79
Price / Operating Cash Flow30.49
Cash Flow & Capital
Free Cash Flow / Share$1.33
Operating Cash Flow / Share$1.51
Free Cash Flow Yield2.87%
Capex / Revenue1.77%
Capex / Operating Cash Flow11.76%
Capex / Depreciation0.48
Stock Compensation / Revenue-1.00%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Liquidity & Leverage
Current Ratio2.30
Quick Ratio1.85
Cash Ratio0.77
Debt / Assets0.36
Debt / Capital0.47
Debt / Equity0.87
Long-Term Debt / Capital0.45
Debt / Market Cap19.49%
Net Debt / EBITDA4.87
Solvency Ratio0.05
Financial Leverage2.43
Efficiency & Working Capital
Asset Turnover0.38
Fixed Asset Turnover5.66
Inventory Turnover0.86
Receivables Turnover3.65
Payables Turnover1.80
Days Sales Outstanding99.91
Days Inventory Outstanding423.78
Days Payables Outstanding202.51
Operating Cycle523.69
Cash Conversion Cycle321.18
Working Capital Turnover2.06
Returns & Quality
Return on Equity3.72%
Return on Assets1.51%
Return on Invested Capital2.12%
ROCE3.14%
Return on Tangible Assets3.25%
Operating Return on Assets2.71%
Income Quality3.80
Tax Burden0.68
Interest Burden0.62
Balance Sheet & Intrinsic Metrics
Enterprise Value$8.77B
Invested Capital$3.51B
Working Capital$860.82M
Tangible Asset Value$-547.18M
Net Current Asset Value$-1.06B
Graham Number$9.85
Graham Net-Net-$8.62
Book Value / Share$10.85
Tangible Book Value / Share-$3.28
Cash / Share$3.94
Financial Health Scores
Piotroski Score4
Altman Z-Score2.28
Revenue$1.67B
EBIT$156.41M
Market Cap$7.76B
Working Capital$860.82M
Retained Earnings$-800.77M
Total Assets$4.39B
Total Liabilities$2.58B